April 26, 2019 06:16 AM EDT
Pharma

DoJ ex­pands crack­down on Medicare kick­back schemes — Astel­las and Am­gen to pay near­ly $125M to re­solve al­le­ga­tions

Natalie Grover

Reporter

Weeks af­ter Jazz Phar­ma, Lund­beck and Alex­ion were dis­ci­plined by the US De­part­ment of Jus­tice for al­leged­ly em­ploy­ing char­i­ta­ble foun­da­tions to help cov­er Medicare …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

Post-Hoc: Biose­cure is dead. Long live Biose­cure? 

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

A service from the Financial Times